0851 GMT - Fresenius Medical Care needs to make progress in order to achieve its targets, UBS analysts say in a note to clients. The company maintained its outlook for 2025 as a whole. It continues to expect revenue to grow by low-single digit percentage and operating profit to grow by high-teens to high-twenties percentage rate. Having delivered only 12% growth in adjusted EBIT in the first half, there is significant work to do in the remainder of the year to reach the mid-to-upper end of guidance, UBS says. Shares are down 3%. (andrea.figueras@wsj.com)
(END) Dow Jones Newswires
August 05, 2025 04:51 ET (08:51 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.